NASDAQ
TRVN

Trevena Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Trevena Inc Stock Price

Vitals

Today's Low:
$0.6801
Today's High:
$0.735
Open Price:
$0.7275
52W Low:
$0.537
52W High:
$5.4825
Prev. Close:
$0.75
Volume:
342076

Company Statistics

Market Cap.:
$10.28 million
Book Value:
0.713
Revenue TTM:
$2.59 million
Operating Margin TTM:
-1599.69%
Gross Profit TTM:
$-3436000
Profit Margin:
0%
Return on Assets TTM:
-49.94%
Return on Equity TTM:
-166.79%

Company Profile

Trevena Inc had its IPO on 2014-01-31 under the ticker symbol TRVN.

The company operates in the Healthcare sector and Biotechnology industry. Trevena Inc has a staff strength of 35 employees.

Stock update

Shares of Trevena Inc opened at $0.73 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.68 - $0.74, and closed at $0.72.

This is a -3.6% slip from the previous day's closing price.

A total volume of 342,076 shares were traded at the close of the day’s session.

In the last one week, shares of Trevena Inc have slipped by -18.4%.

Trevena Inc's Key Ratios

Trevena Inc has a market cap of $10.28 million, indicating a price to book ratio of 0.5689 and a price to sales ratio of 106.0323.

In the last 12-months Trevena Inc’s revenue was $2.59 million with a gross profit of $-3436000 and an EBITDA of $-41079000. The EBITDA ratio measures Trevena Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Trevena Inc’s operating margin was -1599.69% while its return on assets stood at -49.94% with a return of equity of -166.79%.

In Q2, Trevena Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 70%.

Trevena Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-3.92 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Trevena Inc’s profitability.

Trevena Inc stock is trading at a EV to sales ratio of 18.7956 and a EV to EBITDA ratio of 0.1324. Its price to sales ratio in the trailing 12-months stood at 106.0323.

Trevena Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$38.86 million
Total Liabilities
$8.18 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Trevena Inc ended 2024 with $38.86 million in total assets and $0 in total liabilities. Its intangible assets were valued at $38.86 million while shareholder equity stood at $9.78 million.

Trevena Inc ended 2024 with $0 in deferred long-term liabilities, $8.18 million in other current liabilities, 14000.00 in common stock, $-563603000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $28.10 million and cash and short-term investments were $28.10 million. The company’s total short-term debt was $954,000 while long-term debt stood at $14.18 million.

Trevena Inc’s total current assets stands at $32.97 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $2.53 million and inventory worth $901000.00.

In 2024, Trevena Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Trevena Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.72
52-Week High
$5.4825
52-Week Low
$0.537
Analyst Target Price
$6.5

Trevena Inc stock is currently trading at $0.72 per share. It touched a 52-week high of $5.4825 and a 52-week low of $5.4825. Analysts tracking the stock have a 12-month average target price of $6.5.

Its 50-day moving average was $0.92 and 200-day moving average was $1.23 The short ratio stood at 2.83 indicating a short percent outstanding of 0%.

Around 109.5% of the company’s stock are held by insiders while 881.4% are held by institutions.

Frequently Asked Questions About Trevena Inc

The stock symbol (also called stock or share ticker) of Trevena Inc is TRVN

The IPO of Trevena Inc took place on 2014-01-31

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$4.61
0.13
+2.9%
$484.75
-17.3
-3.45%
$72.29
1.12
+1.57%
LifeMD Inc (LFMD)
$4.72
0.03
+0.64%
$0.07
-0.01
-8.36%
$9.45
-0.33
-3.37%
$219.51
-4.03
-1.8%
$244.55
-19.8
-7.49%
$26
-0.64
-2.4%
$85.3
-5.45
-6.01%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.

Address

955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087